eric kline. he's the chairman of the gates mon, you, logical and kidney institute at the cleveland clinic and also a fast offer on this with that. she joins us now from cleveland in our hire doctor, congratulations. hugely exciting news. i see this still needs to be tested and actual screening trials before being rolled out, but could be potentially see this becoming a part of our regular checkup. i believe that we can this is a whole new way of screening for cancer. currently we screen for individual cancers like prostate breast, colon cancer. this would allow screening for multiple cancers in a single drop by my understanding this is so free dna testing, right? so non invasive, which is already being used for other purposes as well. and i know it can be quite expensive. can you give us a sense of the cost of a rollout him whether it would then be available to patients in poor countries potentially well, currently i understand the grill has made it available just in the united states for an out

when i spoke to talk to eric kline, he's the chairman of the glickman, you logical and kidney institution, cleveland clinic, and also fast. also on that research, he's optimistic about what that test could mean for the future of cancer treatment . this is a whole new way of screening for cancer. currently we screen for individual cancers like prostate breast, colon cancer. this would allow screening for multiple cancers in a single drop. currently, i understand that gray has made it available just in the united states or, and out of pocket cost of $949.00, but eventually i could see it being used worldwide. this test will not find ever cancer. on the other hand, the value here is that it will find a lot of cancer is for which we have no screening currently. so it will find a lot of cancer that we don't find. now head neck, pancreatic ovarian, those are cancer's that generally presented advanced stages when patients are symptomatic and the burden of cures high, the amount of treatment needed is high and the courage not very good. so if you look across the entire cancer spectrum, it's true